×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
HURA – tuhura biosciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
HURA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/27
08:00 am
hura
TuHURA Biosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement [Yahoo! Finance]
Medium
Report
TuHURA Biosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement [Yahoo! Finance]
2/27
07:30 am
hura
TuHURA Biosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
Medium
Report
TuHURA Biosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
2/24
05:20 pm
hura
TuHURA Biosciences Announces Participation in Upcoming Investor Conferences
High
Report
TuHURA Biosciences Announces Participation in Upcoming Investor Conferences
2/17
07:45 am
hura
TuHURA Files Investigational New Drug Application for TBS-2025 in the Treatment of Blood-Related Cancers
High
Report
TuHURA Files Investigational New Drug Application for TBS-2025 in the Treatment of Blood-Related Cancers
2/12
07:58 am
hura
TuHURA Biosciences to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
Medium
Report
TuHURA Biosciences to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
2/12
07:45 am
hura
TuHURA Biosciences to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Medium
Report
TuHURA Biosciences to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
2/3
08:03 am
hura
TuHURA Biosciences (NASDAQ:HURA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Medium
Report
TuHURA Biosciences (NASDAQ:HURA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
2/2
08:11 am
hura
TuHURA Biosciences received FDA Orphan Drug Designation for IFx-2.0 for the Treatment of Stage IIB to Stage IV Cutaneous Melanoma [Yahoo! Finance]
Medium
Report
TuHURA Biosciences received FDA Orphan Drug Designation for IFx-2.0 for the Treatment of Stage IIB to Stage IV Cutaneous Melanoma [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
2/17
04:22 pm
hura
Form 4 TuHURA Biosciences, Inc. For: Feb 12 Filed by: Tendler Craig
Low
Report
Form 4 TuHURA Biosciences, Inc. For: Feb 12 Filed by: Tendler Craig
2/17
04:20 pm
hura
Form 4 TuHURA Biosciences, Inc. For: Feb 12 Filed by: Ng George K
Low
Report
Form 4 TuHURA Biosciences, Inc. For: Feb 12 Filed by: Ng George K
2/17
04:19 pm
hura
Form SCHEDULE 13G TuHURA Biosciences, Inc. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Low
Report
Form SCHEDULE 13G TuHURA Biosciences, Inc. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
2/17
04:18 pm
hura
Form 4 TuHURA Biosciences, Inc. For: Feb 12 Filed by: MANUSO JAMES S J
Low
Report
Form 4 TuHURA Biosciences, Inc. For: Feb 12 Filed by: MANUSO JAMES S J
2/17
04:16 pm
hura
Form 4 TuHURA Biosciences, Inc. For: Feb 12 Filed by: List Alan
Low
Report
Form 4 TuHURA Biosciences, Inc. For: Feb 12 Filed by: List Alan
2/17
04:10 pm
hura
Form 4 TuHURA Biosciences, Inc. For: Feb 12 Filed by: Hoffman Robert E.
Low
Report
Form 4 TuHURA Biosciences, Inc. For: Feb 12 Filed by: Hoffman Robert E.
1/30
04:01 pm
hura
Form 8-K TuHURA Biosciences, Inc. For: Jan 29
Medium
Report
Form 8-K TuHURA Biosciences, Inc. For: Jan 29
1/8
04:35 pm
hura
Form 4 TuHURA Biosciences, Inc. For: Jan 06 Filed by: Dearborn Dan
Low
Report
Form 4 TuHURA Biosciences, Inc. For: Jan 06 Filed by: Dearborn Dan
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: